
Managing PoTS: Tips for Living with the Chronic Illness Affecting Millions
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
Imagine standing up and your heart suddenly races as if you've sprinted a mile—except you haven't budged. For millions of Americans with Postural Orthostatic Tachycardia Syndrome (PoTS), this dizzying, exhausting reality is their daily norm.
Though not fatal, PoTS profoundly disrupts everyday life, causing a spectrum of symptoms—dizziness, near‑fainting, brain fog, palpitations, fatigue, tremors, chest discomfort, headaches, nausea and gastrointestinal distress.
Recent data suggest PoTS is on the rise. "PoTS can be triggered by SARS‑CoV‑2 infection as part of long COVID," said Dr. Svetlana Blitshteyn, professor of neurology at the University at Buffalo. A 2025 study in The American Journal of Medicine found that nearly 80 percent of long‑COVID patients met the diagnostic criteria for PoTS.
"Prior to the pandemic, at least 3 to 5 million people had PoTS, which has likely doubled after the pandemic," Blitshteyn told Newsweek.
"We still don't know exactly how many Americans currently have PoTS, but it is estimated that millions more Americans are now suffering from this disease," added Dr. Brit Adler, a professor of medicine in the division of rheumatology at Johns Hopkins University.
File photo: a doctor checks a patient's heart rate and blood pressure in a clinic.
File photo: a doctor checks a patient's heart rate and blood pressure in a clinic.
Klaus Rose/dpa via AP
What Is PoTS?
PoTS is described as an abnormality in the functioning of the autonomic nervous system, the system controlling breathing, gut function, heart rate, blood pressure and many other bodily functions.
It can also be linked to problems like "low blood volume, vascular dysfunction, or other mechanisms," Adler said, adding that those with hypermobility syndromes like Ehlers-Danlos Syndrome often had the condition as well.
PoTS comes as a result of the autonomic nervous system's "adjustment to being upright not functioning properly," Professor Lesley Kavi, the chairperson of the U.K.-based charity organization PoTS UK, told Newsweek.
As many basic tasks in the day require postural changes and standing, a person with PoTS is constantly being put under strain as they navigate simple tasks. Symptoms tend to lessen when a patient is horizontal, but it can sometimes take a long time for symptoms to ease off once flared.
Things like heat, prolonged standing, dehydration, stress, intensive exercise, viruses, infections, and menstruation can all worsen PoTS symptoms.
Kavi said that major surgery, injuries such as concussion, and exposure to a traumatic event can trigger an onset of PoTS, but she added that there isn't enough data and research yet to be able to determine precisely what mechanisms are going wrong within the body.
Dr. Zachary Spiritos, a specialist in gastroenterology and hepatology at North Carolina's UNC Health, told Newsweek: "Many people may be born with a vulnerability, and then something in the environment - often an infection or injury - triggers the onset of symptoms. It's multifactorial, and the exact blend is different for everyone."
How Common Is PoTS?
Prevalence estimates range widely: the Cleveland Clinic cites 1–3 million U.S. cases, while Dysautonomia International reports 3–6 million.
This variability stems largely from under-recognition—most clinicians seldom consider PoTS during evaluation, according to Spiritos. Women account for approximately 80 percent of cases in the U.S., according to Dysautonomia International, likely due to hormonal influences and autoimmune predisposition.
"This is partly because the X chromosome carries many immune-related genes, and women have two copies, which can lead to more robust, but also more error-prone, immune responses," Spiritos said, "[And] we see anecdotal patterns where estrogen can worsen PoTS symptoms, while testosterone may be protective."
What The Experts Recommend For PoTS Patients
Lesley Kavi from PoTS UK said that avoiding symptom triggers can be a good place to start for managing the condition, although this is very individual. For some, this could include avoiding prolonged standing, dehydrating things like the heat, alcohol, and caffeine, she added.
Increasing fluid intake is essential, Kavi said, adding an adult with PoTS should aim to drink between two to three liters of water a day, or more if they exercise or are in a hot environment.
In order to ensure the water stays in your system, increasing sodium intake is also important, Kavi said. Patients are advised to increase their sodium intake to as much as 10,000-12,000 mg per day, but each patient will respond best to a different amount.
Compression clothing, particularly tights or leggings that cover the abdomen, are helpful in boosting blood circulation too, Kavi said. Typically medical grade compression is required of between 20 to 30 mmHg.
"Exercise can be something that helps the most for some people, but the problem with exercise is that it can make others feel really terrible afterwards, even for a day or two," Kavi added.
Starting "low and slow" is always the way to go, Kavi said, adding that it was important to get expert input. The best forms of exercise to start with are horizontal, she added, pointing to exercise bikes, Pilates, rowing machines, and swimming.
Although, it is always best to get professional support, Blitshteyn said. "While there are no cures, there is treatment to help you improve and function better in your life."
It is also important to remember "you're not alone and PoTS is a real, physiologic disorder," Adler said. "Many people go years without a diagnosis and are often told that their symptoms are from anxiety and it is in their head."
Spiritos said it's a good idea to educate yourself, as "understanding the condition is empowering," and recommended listening to the POTScast and Bendy Bodies podcasts.
"Ultimately, community and knowledge are power, and with the right tools, you can get better," he added.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


USA Today
an hour ago
- USA Today
Flu, COVID may 'wake up' dormant cancer cells, new study finds
Respiratory viruses, such as the flu and COVID-19, may be able to 'wake up' dormant cancer cells in patients who have a history of cancer, according to a new study. Researchers tested this hypothesis in mice that contained disseminated cancer cells, which are cells that have broken away from the primary tumor and spread to other organs, where they remain dormant. They exposed the mice to SARS-CoV-2, the virus that causes COVID-19, or the influenza viruses. In both cases, the infections triggered inflammation that awakened the dormant cells located in the lungs, according to the study published July 30 in Nature. 'Dormant cancer cells are like the embers left in an abandoned campfire, and respiratory viruses are like a strong wind that reignites the flames,' said James DeGregori, study senior author and deputy director of the University of Colorado Cancer Center. The study builds on previous studies from 2020 that found COVID-19 doubled patients' risk of dying from cancer. Patients were unvaccinated, so it's unclear if or how this would impact their risk of cancer, said Julio Aguirre-Ghiso, director of the Montefiore Einstein Comprehensive Cancer Center's dormancy institute who co-led the mice study. It's also unclear if there are other factors at play, as the study showed the awakened cancer cells in the mice went back to sleep once the respiratory infection was resolved, he said. 'That indicates that more than one event, caused by viruses or other sources, might be needed for these metastatic cells to grow and become life-threatening,' Aguirre-Ghiso said. More research is needed and the study is 'step one of future efforts.' Adrianna Rodriguez can be reached at adrodriguez@


Newsweek
an hour ago
- Newsweek
Map Shows States Where Tarantulas Are Roaming for Mating Season
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. It's almost tarantula mating season, and in certain states, tens of thousands of tarantulas are expected to crawl out of their burrows to look for mates. Whether you're an arachnophobe or an arachnophile, here's what you need to know about tarantula mating season and the states where the eight-legged creatures can be found. Why It Matters Tarantula mating season typically takes place from late August to October. High temperatures and moisture drive the creatures from their burrows, and males go out to search for partners. While tarantulas in the U.S. are generally not aggressive or harmful to humans, public portrayals of the large spiders—which generally measure about 4 inches or more—may inspire fear in some. Knowing more about the creatures could help relieve those concerns. Which States Have Tarantulas? According to the World Population Review, tarantulas are present in these 13 U.S. states: Arizona Arkansas California Colorado Florida Kansas Louisiana Missouri Nevada New Mexico Oklahoma Texas Utah Generally speaking, tarantulas prefer dry climates and live in Western and Southwestern states. However, they can be found in other states, and their location can depend on the species of tarantula. What Kinds of Tarantulas Are in the U.S.? The U.S. is home to about 29 species of tarantula, which primarily belong to the Theraphosidae family. Here are some of the tarantulas that can be found in the country: Aphonopelma hentzi—Texas brown tarantula. This is one of the most common species in the U.S. It is found in multiple states and reaches a 4- to 5-inch leg span. Aphonopelma chalcodes—desert blonde tarantula. Native to Arizona, this tarantula inhabits desert regions and is known for its long life span. Aphonopelma iodius—Great Basin blonde tarantula. Found in the California, Nevada and Utah deserts, females of this species can live for more than 30 years in captivity. Aphonopelma anax—Texas tan tarantula. This species is native to southern Texas and northern Mexico, and it is one of the largest species in the U.S., reaching a 5- to 6-inch leg span. Generally, tarantulas that are seen out and about are males as females are "homebodies who don't travel far from their individual burrows," according to the National Park Service. Females live longer than males, sometimes up to 25 years while males live up to 10 years. This is partly because of males going on their mating journeys and encountering danger on the way. A tarantula walks at El Impenetrable National Park, Chaco province, Argentina, on October 28, 2022. A tarantula walks at El Impenetrable National Park, Chaco province, Argentina, on October 28, 2022. LUIS ROBAYO/AFP via Getty Images Are Tarantulas Dangerous to People? According to the National Park Service, tarantulas are not aggressive or deadly, despite portrayals in pop culture. The service describes them as docile, adding that though they are capable of biting a person, this mostly happens if they are harassed, and bites are rare. Additionally, their venom is not considered to be toxic to humans. What Happens Next The mating season is set to last until the fall. According to World Population Review, "if you see a tarantula in your home, you should not kill it. Keep in mind that tarantulas are going to kill a lot of the most common pests that you might find in your home." The data site added, "If you feel like you can do so safely, try to catch it in a container. Then, release it in the wild."


Newsweek
an hour ago
- Newsweek
Respiratory Viruses Risk Waking Dormant Cancer
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Respiratory infections like COVID-19 and the flu may increase the risk of dormant breast cancer cells reactivating and spreading in those with a history of the disease. This is the conclusion of a study based on experiments with mice and observational human health data by researchers at the University of Colorado, the Montefiore Einstein Comprehensive Cancer Center (MECCC) in New York and Utrecht University. Such an awakening, the team warn, could trigger new metastatic tumors. "Dormant cancer cells are like the embers left in an abandoned campfire—and respiratory viruses are like a strong wind that reignites the flames," said paper author James DeGregori of the University of Colorado Cancer Center in a statement. The findings highlight the need for patients to be aware of the risk between infection and cancer spread. For affected patients, "The simplest strategy would be to avoid infection (vaccination, avoiding crowded places during flu season, etc)," DeGregori told Newsweek. An illustration of cancer cells marked with green, and the proliferation of cells marked in magenta. An illustration of cancer cells marked with green, and the proliferation of cells marked in magenta. Michael DeGregori Breast cancer is the most common cancer in women. Around 316,950 new cases of invasive breast cancer will be diagnosed in women in the U.S. this year, with more than 42,000 women expected to die from the disease this year alone, according to the American Cancer Society. After remission, cancer cells may remain dormant for years before spreading— notably in the lungs or other organs—and causing a relapse. As viral respiratory infections like SARS-CoV-2 (the virus that causes COVID-19) are associated with inflammation, this may trigger processes that could cause cancer cells to spread. A rise in cancer death rates in the first two years of the pandemic led DeGregori and his colleagues to study the effects of the influenza virus and SARS-CoV-2 infections on breast cancer outcomes in mouse models. They determined that these infections reduced the dormancy of breast cancer cells in the lungs. The cancer cells multiplied within days of infection, leading to the expansion of metastatic cancer lesions within two weeks. Inflammatory pathways are implicated in this effect, the researchers found. "The study proves that the general phenomenon can also be observed in humans. Of course, the authors cannot prove that it is the same mechanism, as these are epidemiological data," said professor Carsten Watzl, Scientific Director of the Immunology Research Unit of the Leibniz Research Centre for Working Environment and Human Factors Dortmund. An image showing the awakening of dormant cancer cells. An image showing the awakening of dormant cancer cells. Bryan Johnson Analysis of molecules revealed that the awakening of dormant cancer cells is driven by a protein called interleukin-6 (IL-6), which immune cells release in response to infections or injuries. "The identification of IL-6 as a key mediator in arousing DCCs from dormancy suggests that using IL-6 inhibitors or other targeted immunotherapies might prevent or lessen the resurgence of metastasis following viral infection," said paper author and MECCC cell biologist Julio Aguirre-Ghiso said in a statement. The researchers also examined whether patients with cancer that tested positive for COVID-19 might have an increased risk of cancer-related death, analyzing data from the UK Biobank (4,837 participants, all cancer types) and Flatiron Health (36,845 patients with breast cancer) databases. They discovered an association between SARS-CoV-2 infection and risk of death in the Biobank group. Patients that tested positive SARS-CoV-2 showed a twofold increase in cancer-related death compared to those who were negative. In the Flatiron group, the infection was associated with an increase of more than 40 percent in the risk of metastatic disease in the lungs. It should be noted the new study focused on the period before COVID-19 vaccines were available. Although the studies were limited to those previously diagnosed with cancer, or mice that had dormant cells already when infected, DeGregori cautioned that the team, "couldn't rule out an effect on those with active cancer." Cell and molecular biologist John Alcorn of the University of Pittsburg told Newsweek, "This study does not address how bad of a COVID or flu infection is needed to trigger this type of response. Another prevention would be to have imaging done if you are a cancer patient in remission who gets a viral pneumonia. This could lead to early detection or resurgence and increased treatment options." DeGregori added: "Additional research and clinical studies will be needed for the development of interventions that could be applied during the infection, and we are actively working to develop such interventions." The researchers plan to extend their analyses, both in animal models and of clinical data, to other cancer types and areas of metastatic disease. Do you have a tip on a health story that Newsweek should be covering? Do you have a question about breast cancer? Let us know via health@ Reference Chia, S. B., Johnson, B. J., Hu, J., Valença-Pereira, F., Chadeau-Hyam, M., Guntoro, F., Montgomery, H., Boorgula, M. P., Sreekanth, V., Goodspeed, A., Davenport, B., De Dominici, M., Zaberezhnyy, V., Schleicher, W. E., Gao, D., Cadar, A. N., Petriz-Otaño, L., Papanicolaou, M., Beheshti, A., Baylin, S. B., ... DeGregori, J. (2025). Respiratory viral infections awaken metastatic breast cancer cells in lungs. Nature.